Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Trans fat labeling

This article was originally published in The Tan Sheet

Executive Summary

FDA has added an addendum to its recent guidance on requesting an extension to use existing label stock after the trans fat labeling effective date of Jan. 1, the agency said Dec. 30. Due to the "numerous requests" from industry on the guidance and the agency's "limited resources to handle all of these pending requests prior to the Jan. 1 effective date," FDA will only consider requests postmarked as of Dec. 31. In order to be considered, the requests must be for product labels that otherwise comply with FDA labeling requirements. The product also must not contain more than 0.5 g trans fat per labeled serving. The labeling guidance was released Dec. 14 (1"The Tan Sheet" Dec. 12, 2005, In Brief)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098991

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel